Clin Psychopharmacol Neurosci.  2015 Apr;13(1):115-117. 10.9758/cpn.2015.13.1.115.

Dystonia in an Adolescent on Risperidone Following the Discontinuation of Methylphenidate: A Case Report

Affiliations
  • 1Department of Child and Adolescent Psychiatry, Mersin University Medical Faculty, Mersin, Turkey. dr.gulen@hotmail.com
  • 2Department of Child and Adolescent Psychiatry, Baskent University Medical Faculty, Adana, Turkey.

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with common comorbidities that include oppositional defiant disorder, conduct disorder, anxiety disorder, and affective disorders. Because of these comorbidities, drug combination treatments and drug-drug interactions are becoming increasingly more frequent. The present case report describes an acute dystonic reaction following the abrupt discontinuation of methylphenidate from a drug regimen with risperidone. The patient experienced acute dystonic reactions on three separate occasions when he forgot to take his methylphenidate medication. The present report informs clinicians about the possible side effects, such as dystonia, when psychostimulant and antipsychotic drug combinations are altered and suggests that the abrupt cessation of stimulants may lead to the development of movement disorders. Therefore, appropriate care is necessary when changing the dose of a drug or abruptly discontinuing a drug from a combination of psychostimulants and antipsychotics.

Keyword

Dystonia; Methylphenidate; Antipsychotic agents; Drug combinations

MeSH Terms

Adolescent*
Antipsychotic Agents
Anxiety Disorders
Attention Deficit and Disruptive Behavior Disorders
Comorbidity
Conduct Disorder
Drug Combinations
Dystonia*
Humans
Methylphenidate*
Mood Disorders
Movement Disorders
Risperidone*
Antipsychotic Agents
Drug Combinations
Methylphenidate
Risperidone
Full Text Links
  • CPN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr